MHRA Chief On How The UK Agency Is Overhauling Its Processes To Overcome Post-Brexit Challenges

The Medicines and Healthcare products Regulatory Agency has introduced a series of changes, including an upcoming overhaul of its clinical trial legislation, to enhance its performance in the future, chief executive Dame June Raine writes.